Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 261

1.

Hepcidin expression in anemia of chronic disease and concomitant iron-deficiency anemia.

Cheng PP, Jiao XY, Wang XH, Lin JH, Cai YM.

Clin Exp Med. 2011 Mar;11(1):33-42. doi: 10.1007/s10238-010-0102-9. Epub 2010 May 25.

PMID:
20499129
2.

Growth differentiation factor 15 in anaemia of chronic disease, iron deficiency anaemia and mixed type anaemia.

Theurl I, Finkenstedt A, Schroll A, Nairz M, Sonnweber T, Bellmann-Weiler R, Theurl M, Seifert M, Wroblewski VJ, Murphy AT, Witcher D, Zoller H, Weiss G.

Br J Haematol. 2010 Feb;148(3):449-55. doi: 10.1111/j.1365-2141.2009.07961.x. Epub 2009 Oct 15.

PMID:
19863534
3.

Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications.

Theurl I, Aigner E, Theurl M, Nairz M, Seifert M, Schroll A, Sonnweber T, Eberwein L, Witcher DR, Murphy AT, Wroblewski VJ, Wurz E, Datz C, Weiss G.

Blood. 2009 May 21;113(21):5277-86. doi: 10.1182/blood-2008-12-195651. Epub 2009 Mar 17.

4.

Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia.

van Santen S, van Dongen-Lases EC, de Vegt F, Laarakkers CM, van Riel PL, van Ede AE, Swinkels DW.

Arthritis Rheum. 2011 Dec;63(12):3672-80. doi: 10.1002/art.30623.

5.

Anaemia in patients with cancer: role of inflammatory activity on iron metabolism and severity of anaemia.

Jacober ML, Mamoni RL, Lima CS, Dos Anjos BL, Grotto HZ.

Med Oncol. 2007;24(3):323-9.

PMID:
17873309
6.

Evaluation of serum transferrin receptor and sTfR ferritin indices in diagnosing and differentiating iron deficiency anemia from anemia of chronic disease.

Jain S, Narayan S, Chandra J, Sharma S, Jain S, Malhan P.

Indian J Pediatr. 2010 Feb;77(2):179-83. doi: 10.1007/s12098-009-0302-z. Epub 2010 Jan 20.

PMID:
20091370
7.

[Serum hepcidin levels in geriatric patients with iron deficiency anemia or anemia of chronic diseases].

Röhrig G, Rappl G, Vahldick B, Kaul I, Schulz RJ.

Z Gerontol Geriatr. 2014 Jan;47(1):51-6. doi: 10.1007/s00391-013-0508-6. German.

PMID:
23743883
8.

Serum hepcidin-25 may replace the ferritin index in the Thomas plot in assessing iron status in anemic patients.

Thomas C, Kobold U, Balan S, Roeddiger R, Thomas L.

Int J Lab Hematol. 2011 Apr;33(2):187-93. doi: 10.1111/j.1751-553X.2010.01265.x. Epub 2010 Sep 27.

PMID:
20868446
9.
10.

Serum hepcidin: a direct link between anemia of inflammation and coronary artery atherosclerosis in patients with rheumatoid arthritis.

Abdel-Khalek MA, El-Barbary AM, Essa SA, Ghobashi AS.

J Rheumatol. 2011 Oct;38(10):2153-9. doi: 10.3899/jrheum.110339. Epub 2011 Sep 1.

PMID:
21885483
11.

Serum pro-hepcidin level and iron homeostasis in Japanese dialysis patients with erythropoietin (EPO)-resistant anemia.

Shinzato T, Abe K, Furusu A, Harada T, Shinzato K, Miyazaki M, Kohno S.

Med Sci Monit. 2008 Sep;14(9):CR431-7.

PMID:
18758412
12.

Hepcidin and anaemia.

Means RT Jr.

Blood Rev. 2004 Dec;18(4):219-25. Review.

PMID:
15501550
13.

Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anemia of chronic disease.

Theurl I, Mattle V, Seifert M, Mariani M, Marth C, Weiss G.

Blood. 2006 May 15;107(10):4142-8. Epub 2006 Jan 24.

14.

Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index.

Skikne BS, Punnonen K, Caldron PH, Bennett MT, Rehu M, Gasior GH, Chamberlin JS, Sullivan LA, Bray KR, Southwick PC.

Am J Hematol. 2011 Nov;86(11):923-7. doi: 10.1002/ajh.22108. Epub 2011 Aug 2.

15.

Iron regulatory hormone hepcidin decreases in chronic heart failure patients with anemia.

Matsumoto M, Tsujino T, Lee-Kawabata M, Naito Y, Akahori H, Sakoda T, Ohyanagi M, Tomosugi N, Masuyama T.

Circ J. 2010 Feb;74(2):301-6. Epub 2009 Dec 18.

16.

Usefulness of soluble transferrin receptor and ferritin in iron deficiency and chronic disease.

Marković M, Majkić-Singh N, Subota V.

Scand J Clin Lab Invest. 2005;65(7):571-6.

PMID:
16271988
18.

Iron-deficiency anemia in Castleman disease: implication of the interleukin 6/hepcidin pathway.

Arlet JB, Hermine O, Darnige L, Ostland V, Westerman M, Badoual C, Pouchot J, Capron L.

Pediatrics. 2010 Dec;126(6):e1608-12. doi: 10.1542/peds.2010-1123. Epub 2010 Nov 1.

PMID:
21041280
19.

Serum hepcidin in clinical specimens.

Dallalio G, Fleury T, Means RT.

Br J Haematol. 2003 Sep;122(6):996-1000.

PMID:
12956771
20.

Hepcidin expression and iron parameters change in Type 2 diabetic patients.

Jiang F, Sun ZZ, Tang YT, Xu C, Jiao XY.

Diabetes Res Clin Pract. 2011 Jul;93(1):43-8. doi: 10.1016/j.diabres.2011.03.028. Epub 2011 Apr 21.

PMID:
21513996

Supplemental Content

Support Center